David J. Mazzo - 09 Jan 2026 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jan 2026, 16:09:54 UTC
Prior SEC filing
13 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
James Nisco, Attorney-in-Fact for David J. Mazzo

Key filing fact

David J. Mazzo filed Form 4 for LISATA THERAPEUTICS, INC. (LSTA) on 13 Jan 2026.

Key facts

  • This page summarizes David J. Mazzo's Form 4 filing for LISATA THERAPEUTICS, INC. (LSTA).
  • 6 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Jan 2026, 16:09.

Change

  • Previous filing in this sequence was filed on 13 Jan 2025.
  • Current net transaction value: -$80,959.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001334549 Primary reporting owner

Mazzo David J

Relationship
President & CEO, Director
Address
C/O LISATA THERAPEUTICS, INC., 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE
Signature
James Nisco, Attorney-in-Fact for David J. Mazzo
Signature date
13 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LSTA transaction

Common Stock

Award

Transaction value
$0
Shares
+81,000
Change %
+30%
Price
$0.000000
Shares after
352,986
Date
09 Jan 2026
Ownership
Direct
Footnotes
F1, F2
LSTA transaction

Common Stock

Tax liability

Transaction value
$20,691
Shares
-10,503
Change %
-3%
Price
$1.97
Shares after
342,483
Date
09 Jan 2026
Ownership
Direct
Footnotes
F2, F3
LSTA transaction

Common Stock

Tax liability

Transaction value
$20,715
Shares
-10,515
Change %
-3.1%
Price
$1.97
Shares after
331,968
Date
09 Jan 2026
Ownership
Direct
Footnotes
F2, F3
LSTA transaction

Common Stock

Tax liability

Transaction value
$24,081
Shares
-12,224
Change %
-3.7%
Price
$1.97
Shares after
319,744
Date
09 Jan 2026
Ownership
Direct
Footnotes
F2, F3
LSTA transaction

Common Stock

Tax liability

Transaction value
$15,472
Shares
-7,854
Change %
-2.5%
Price
$1.97
Shares after
311,890
Date
09 Jan 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LSTA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+40,000
Change %
Price
$0.000000
Shares after
40,000
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$1.97
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.

Footnote F2

Includes 124,750 unvested restricted stock.

Footnote F3

Shares withheld as payment of a tax liability on vesting of restricted stock.

Footnote F4

One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .